A detailed history of Csenge Advisory Group transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Csenge Advisory Group holds 3,807 shares of TMO stock, worth $2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
3,807
Previous 3,740 1.79%
Holding current value
$2 Million
Previous $2.07 Million 13.83%
% of portfolio
0.12%
Previous 0.12%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$531.86 - $624.21 $35,634 - $41,822
67 Added 1.79%
3,807 $2.35 Million
Q2 2024

Jul 10, 2024

BUY
$541.52 - $599.02 $105,054 - $116,209
194 Added 5.47%
3,740 $2.07 Million
Q1 2024

May 03, 2024

BUY
$528.82 - $599.43 $83,553 - $94,709
158 Added 4.66%
3,546 $2.06 Million
Q4 2023

Feb 13, 2024

SELL
$431.41 - $532.94 $87,144 - $107,653
-202 Reduced 5.63%
3,388 $1.8 Million
Q3 2023

Nov 01, 2023

SELL
$498.29 - $574.41 $42,852 - $49,399
-86 Reduced 2.34%
3,590 $1.82 Million
Q2 2023

Jul 20, 2023

BUY
$508.46 - $591.13 $83,387 - $96,945
164 Added 4.67%
3,676 $1.92 Million
Q1 2023

May 01, 2023

SELL
$535.0 - $604.82 $197,415 - $223,178
-369 Reduced 9.51%
3,512 $2.02 Million
Q4 2022

Feb 10, 2023

BUY
$484.71 - $571.37 $152,683 - $179,981
315 Added 8.83%
3,881 $2.14 Million
Q3 2022

Oct 04, 2022

BUY
$507.19 - $604.49 $283,519 - $337,909
559 Added 18.59%
3,566 $1.81 Million
Q2 2022

Jul 27, 2022

BUY
$500.9 - $612.21 $116,208 - $142,032
232 Added 8.36%
3,007 $1.63 Million
Q1 2022

May 09, 2022

BUY
$524.0 - $644.92 $224,796 - $276,670
429 Added 18.29%
2,775 $1.64 Million
Q4 2021

Feb 10, 2022

SELL
$569.0 - $667.24 $46,089 - $54,046
-81 Reduced 3.34%
2,346 $1.2 Million
Q3 2021

Oct 20, 2021

BUY
$509.53 - $609.78 $41,271 - $49,392
81 Added 3.45%
2,427 $1.39 Million
Q2 2021

Jul 21, 2021

BUY
$441.0 - $508.24 $656,649 - $756,769
1,489 Added 173.75%
2,346 $1.2 Million
Q1 2021

Apr 28, 2021

SELL
$439.85 - $518.83 $58,939 - $69,523
-134 Reduced 13.52%
857 $410,000
Q4 2020

Jan 26, 2021

SELL
$435.06 - $527.66 $98,758 - $119,778
-227 Reduced 18.64%
991 $462,000
Q3 2020

Nov 09, 2020

SELL
$359.77 - $441.52 $719 - $883
-2 Reduced 0.16%
1,218 $543,000
Q2 2020

Jul 17, 2020

BUY
$275.2 - $362.34 $60,819 - $80,077
221 Added 22.12%
1,220 $442,000
Q1 2020

Apr 21, 2020

BUY
$255.3 - $340.05 $255,044 - $339,709
999 New
999 $283,000
Q4 2018

Feb 07, 2019

SELL
$208.47 - $251.98 $16,886 - $20,410
-81 Closed
0 $0
Q3 2018

Nov 19, 2018

SELL
$205.57 - $244.32 $304,654 - $362,082
-1,482 Reduced 94.82%
81 $19,000
Q2 2018

Aug 10, 2018

BUY
$203.14 - $219.53 $21,329 - $23,050
105 Added 7.2%
1,563 $332,000
Q1 2018

May 10, 2018

BUY
$192.98 - $224.11 $281,364 - $326,752
1,458 New
1,458 $301,000
Q4 2017

Feb 15, 2018

SELL
$182.03 - $200.37 $193,679 - $213,193
-1,064 Closed
0 $0
Q3 2017

Oct 31, 2017

BUY
$171.74 - $194.04 $182,731 - $206,458
1,064
1,064 $0

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $206B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.